(Total Views: 635)
Posted On: 05/20/2020 3:56:54 PM
Post# of 155266
The remdesivir trial was placebo controlled:
https://www.nih.gov/news-events/news-releases...d-covid-19
There is plenty to be critical about with this trial, mainly midstream changing the endpoints to fit what was being observed in other trials; but, it was placebo controlled.
We can expect much better results with leronlimab.
https://www.nih.gov/news-events/news-releases...d-covid-19
There is plenty to be critical about with this trial, mainly midstream changing the endpoints to fit what was being observed in other trials; but, it was placebo controlled.
We can expect much better results with leronlimab.
(1)
(0)
